98%
921
2 minutes
20
The nonpathogenic fowl adenoviruses (FAdVs) are suitable recombinant virus vectors. Two different replication-competent FAdV-9-based recombinant viruses carrying the enhanced green fluorescent protein (EGFP) gene within a nonessential DNA sequence at the left end genomic region were tested in chickens to study the antibody response by enzyme-linked immunosorbent assay to both the foreign proteins, EGFP and FAdV-9, and virus shedding through the feces. All inoculations were done intramuscularly: groups 1 and 2 with the recombinant viruses and group 3 with the wild-type FAdV-9 virus. Group 4 was mock inoculated. Sentinel birds also were included in groups 1-3 to study virus transmission. Boosting inoculations were done in all groups at 2, 3, and 4 wk after the first inoculation. Antibodies to EGFP were detected at 3-7 wk postinoculation in groups 1 and 2 only. Antibody response to FAdV-9 in groups 1-3 did not differ significantly (P > 0.06). Virus was not detected in the feces of chickens in groups 1 and 2, including the sentinel birds, but virus was present in the feces of chickens in group 3, including the sentinel birds. These results further supported our previous findings regarding the suitability of the nonessential region at the left end of the viral genome as an insertion site for foreign genes and its importance in in vivo replication. In this work, we demonstrated the potential of FAdV-9-based recombinant viruses as vaccines for poultry.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1637/9710-031311-Reg.1 | DOI Listing |
J Virol
September 2025
Division of Pediatric Infectious Disease, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Rift Valley fever virus (RVFV) causes mild to severe disease in livestock and humans. It was first identified in 1931 during an epizootic in Kenya and has spread across Africa and into the Middle East. Hematopoietic cells are one of the major targets of RVFV ; however, their contribution to RVFV pathogenesis remains poorly understood.
View Article and Find Full Text PDFInvest Ophthalmol Vis Sci
September 2025
Department of Ophthalmology, Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States.
Purpose: Adeno-associated viruses (AAVs) have become the preferred vector for gene therapy in ophthalmology. However, requirements for specific cell surface receptors limit AAV-mediated retinal cell transduction efficiency. This led to the need to engineer novel AAV vectors for widespread retinal transduction and transgene expression.
View Article and Find Full Text PDFVirus Evol
August 2025
College of Biology, Hunan Provincial Key Laboratory of Medical Virology, Hunan Research Center of the Basic Discipline for Cell Signaling, Hunan University, 52 Tianma Rd, Changsha, Hunan, 410012, China.
(γ-CoV) primarily infects poultry, wild birds, and marine mammals. The widespread distribution and circulation of γ-CoV in the ecological environment may lead to sustained transmission and economic loss. To better understand the diversity of γ-CoV in wild birds, we collected 482 wild-bird faecal samples from Yunnan, encompassing 14 bird species.
View Article and Find Full Text PDFMol Ther Methods Clin Dev
September 2025
School of Natural Sciences, University of Kent, Canterbury, Kent CT2 7NJ, UK.
Accurate quantification and characterization of recombinant adeno-associated virus (rAAV) capsid proteins are critical for evaluating product quality and safety, ensuring batch consistency, and informing process development of their manufacture. The capsid consists of three proteins derived from the same gene, and while the mean capsid stoichiometry is nominally 1:1:10 (VP1:VP2:VP3), capsids with different stoichiometries exist. Recent studies show that variations in the capsid stoichiometry can impact vector infectivity.
View Article and Find Full Text PDFMol Ther Methods Clin Dev
September 2025
Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland.
Recombinant adeno-associated viruses (rAAV) have emerged as a preferred strategy for gene delivery. However, the immune response to rAAV presents a major limitation, leading to serious adverse events in clinical trials. This study investigates the interaction between rAAV and the innate immune system.
View Article and Find Full Text PDF